Orthogonal at Heart Rhythm 2017 in Chicago

Bernhard Kappe
Bernhard Kappe

Join Orthogonal CEO Bernhard Kappe and other industry experts at Heart Rhythm 2017, May 10-13, 2017 at McCormick Place in Chicago, IL. Joining Kappe will be Nanowear CEO Venk Varadan and other Orthogonal clients.

Industry expert presentations in Rhythm Theatres will be offered in the exhibit hall providing valuable opportunities for attendees to learn about new data and advances in the latest clinical information and innovation.

Of particular interest is the following can’t-miss session:

Rhythm Theatre 1 – 2201, Exhibit Hall, Wednesday, May 10, 5:15 – 6:15 pm
Driving Patient Experience, Satisfaction and Outcomes with App-Based Monitoring
Explore real world efforts and results from clinicians who are successfully incorporating app-based patient monitors into their practice.

Speaker: Khaldoun Tarakji, MD, MPH
Cleveland Clinic Foundation, Cleveland, OH

Connected care is moving into a number of significant clinical areas, including cardiac monitoring and pacing as well as the monitoring of other vital systems. In keeping with the conference theme, Orthogonal client Nanowear’s SimplECG™ wearable monitoring system received FDA clearance in December 2016. Using a network of proprietary biosensors embedded within everyday undergarments such as brassieres and t-shirts, it provides remote, continuous monitoring and simultaneously provides medical practitioners with a flexible, cost-effective platform to make informed decisions.

Another stellar example of this ground-breaking technology is Orthogonal client PhysIQ’s proven, first-of-its-kind data analytics platform designed to process multiple vital signs from wearable sensors that map them — and in so doing, detect subtle deviations in vitals that may be a precursor to disease exacerbation or a critical change in the patient’s health.

The Heart Rhythm Society’s 38th Annual Scientific Sessions will convene the finest clinicians, scientists, researchers and innovators in the field of cardiac pacing and electrophysiology. Learn more at:

If you’re interested in learning more about app-based monitoring and Orthogonal’s companion software development services in the cardiology space, contact us to schedule a meeting at HRS.

Related Posts


Help Us Build an Authoritative List of SaMD Cleared by the FDA


SaMD Cleared by the FDA: The Ultimate Running List


Roundup: Bluetooth Medical Devices Cleared by FDA in 2023

White Paper

Software as a Medical Device (SaMD): What It Is & Why It Matters